Boothbay Fund Management, LLC I Mab Transaction History
Boothbay Fund Management, LLC
- $3.6 Billion
- Q3 2024
A detailed history of Boothbay Fund Management, LLC transactions in I Mab stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 1,419,080 shares of IMAB stock, worth $1.33 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,419,080
Previous 1,379,352
2.88%
Holding current value
$1.33 Million
Previous $2.3 Million
23.62%
% of portfolio
0.05%
Previous 0.07%
Shares
8 transactions
Others Institutions Holding IMAB
# of Institutions
36Shares Held
15.5MCall Options Held
56.4KPut Options Held
5.8K-
Hhlr Advisors, Ltd. Grand Cayman, E96.91MShares$6.49 Million0.2% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.17MShares$3.92 Million3.04% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U0567KShares$532,6510.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny499KShares$469,3420.0% of portfolio
-
Two Sigma Investments, LP New York, NY409KShares$384,0070.0% of portfolio
About I-Mab
- Ticker IMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,098,800
- Market Cap $78.1M
- Description
- I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...